Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Pseudomonas aeruginosa population structure revisited under environmental focus: impact of water quality and phage pressure.

Selezska K, Kazmierczak M, Müsken M, Garbe J, Schobert M, Häussler S, Wiehlmann L, Rohde C, Sikorski J.

Environ Microbiol. 2012 Aug;14(8):1952-67. doi: 10.1111/j.1462-2920.2012.02719.x. Epub 2012 Mar 6.

PMID:
22390474
2.

Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilms.

Pires D, Sillankorva S, Faustino A, Azeredo J.

Res Microbiol. 2011 Oct;162(8):798-806. doi: 10.1016/j.resmic.2011.06.010. Epub 2011 Jul 5.

PMID:
21782936
3.

Association patterns of Pseudomonas aeruginosa clinical isolates as revealed by virulence traits, antibiotic resistance, serotype and genotype.

Fonseca AP, Correia P, Sousa JC, Tenreiro R.

FEMS Immunol Med Microbiol. 2007 Dec;51(3):505-16. Epub 2007 Sep 17.

5.

Spatio-temporal analysis of infra-specific genetic variations among a Pseudomonas aeruginosa water network hospital population: invasion and selection of clonal complexes.

Lavenir R, Sanroma M, Gibert S, Crouzet O, Laurent F, Kravtsoff J, Mazoyer MA, Cournoyer B.

J Appl Microbiol. 2008 Nov;105(5):1491-501. doi: 10.1111/j.1365-2672.2008.03907.x.

6.

In vitro and in vivo antibacterial activity of environmental bacteriophages against Pseudomonas aeruginosa strains from cystic fibrosis patients.

Olszak T, Zarnowiec P, Kaca W, Danis-Wlodarczyk K, Augustyniak D, Drevinek P, de Soyza A, McClean S, Drulis-Kawa Z.

Appl Microbiol Biotechnol. 2015 Jul;99(14):6021-33. doi: 10.1007/s00253-015-6492-6. Epub 2015 Mar 12.

7.

Genotypic analysis of UK keratitis-associated Pseudomonas aeruginosa suggests adaptation to environmental water as a key component in the development of eye infections.

Shankar J, Sueke H, Wiehlmann L, Horsburgh MJ, Tuft S, Neal TJ, Kaye SB, Winstanley C.

FEMS Microbiol Lett. 2012 Sep;334(2):79-86. doi: 10.1111/j.1574-6968.2012.02621.x. Epub 2012 Jul 3.

8.

Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment.

Finnan S, Morrissey JP, O'Gara F, Boyd EF.

J Clin Microbiol. 2004 Dec;42(12):5783-92.

9.

Pseudomonas aeruginosa adaptation to lungs of cystic fibrosis patients leads to lowered resistance to phage and protist enemies.

Friman VP, Ghoul M, Molin S, Johansen HK, Buckling A.

PLoS One. 2013 Sep 19;8(9):e75380. doi: 10.1371/journal.pone.0075380. eCollection 2013.

10.

In vitro management of hospital Pseudomonas aeruginosa biofilm using indigenous T7-like lytic phage.

Ahiwale S, Tamboli N, Thorat K, Kulkarni R, Ackermann H, Kapadnis B.

Curr Microbiol. 2011 Feb;62(2):335-40. doi: 10.1007/s00284-010-9710-6. Epub 2010 Aug 14.

PMID:
20711581
11.

Characterisation of potential virulence markers in Pseudomonas aeruginosa isolated from drinking water.

Silva ME, Filho IC, Endo EH, Nakamura CV, Ueda-Nakamura T, Filho BP.

Antonie Van Leeuwenhoek. 2008 May;93(4):323-34. Epub 2007 Nov 24.

PMID:
18038252
12.

Formation of biofilms under phage predation: considerations concerning a biofilm increase.

Hosseinidoust Z, Tufenkji N, van de Ven TG.

Biofouling. 2013;29(4):457-68. doi: 10.1080/08927014.2013.779370.

PMID:
23597188
14.

Are clinical isolates of Pseudomonas aeruginosa more virulent than hospital environmental isolates in amebal co-culture test?

Fenner L, Richet H, Raoult D, Papazian L, Martin C, La Scola B.

Crit Care Med. 2006 Mar;34(3):823-8.

PMID:
16505663
15.

Bacteriophage and phenotypic variation in Pseudomonas aeruginosa biofilm development.

Webb JS, Lau M, Kjelleberg S.

J Bacteriol. 2004 Dec;186(23):8066-73.

16.

Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis.

Choy MH, Stapleton F, Willcox MD, Zhu H.

J Med Microbiol. 2008 Dec;57(Pt 12):1539-46. doi: 10.1099/jmm.0.2008/003723-0.

PMID:
19018027
17.

Worldwide distribution of Pseudomonas aeruginosa clone C strains in the aquatic environment and cystic fibrosis patients.

Römling U, Kader A, Sriramulu DD, Simm R, Kronvall G.

Environ Microbiol. 2005 Jul;7(7):1029-38.

PMID:
15946300
18.

Bacteriophages of Pseudomonas aeruginosa: long-term prospects for use in phage therapy.

Krylov VN.

Adv Virus Res. 2014;88:227-78. doi: 10.1016/B978-0-12-800098-4.00005-2. Review.

PMID:
24373314
19.

Isolation of Pseudomonas aeruginosa from open ocean and comparison with freshwater, clinical, and animal isolates.

Khan NH, Ishii Y, Kimata-Kino N, Esaki H, Nishino T, Nishimura M, Kogure K.

Microb Ecol. 2007 Feb;53(2):173-86.

PMID:
17206394
20.

A major Pseudomonas aeruginosa clone common to patients and aquatic habitats.

Römling U, Wingender J, Müller H, Tümmler B.

Appl Environ Microbiol. 1994 Jun;60(6):1734-8.

Items per page

Supplemental Content

Write to the Help Desk